Your session is about to expire
← Back to Search
Aerobic Exercise for Alzheimer's Disease (BIMII Trial)
BIMII Trial Summary
This trial will test an exercise intervention for secondary prevention of ADRD in adults at increased risk for ADRD. The rationale for this trial is the urgent need for dementia prevention.
BIMII Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BIMII Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 50-80 years old, feel I have memory issues, but don't have dementia, and have risk factors for Alzheimer's or related diseases.I have a history of high blood pressure, diabetes, obesity (BMI <40), high cholesterol, smoking, or past heart disease without recent symptoms.I am not fluent in English.I have had a stroke in the past.
- Group 1: Stretch and Strength
- Group 2: Aerobic exercise
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research include elderly patients as participants?
"This research project is open to patients who are within the ages of 50 and 80."
Who meets the qualifications to take part in this research endeavor?
"This study is actively seeking 264 men and women between the ages of 50-80 who are experiencing cognitive decline, but have yet to be diagnosed with dementia. These candidates must also meet certain risk factors such as inactivity (as gauged by a physical activity questionnaire), obesity, hypertension, smoking history, and prior coronary artery disease without recent symptoms (<5 years). Additionally all potential participants must provide approval from their doctor or receive information on how to locate one for that purpose using a PAR-Q+ form. Lastly subjective cognitive complaints will be measured via MAC-Q Memory Complaint Questionnaire; those scoring above 25 will qualify for enrolment."
Are there any vacancies left for participants in this clinical research?
"According to the clinicaltrials.gov website, this research initiative is currently welcoming individuals who meet certain criteria. The project was inaugurated on January 1st 2017 and its details were most recently edited on November 2nd 2022."
How many test subjects have been recruited to be part of this clinical trial?
"Affirmative. Clinicaltrials.gov verifies that this clinical trial is currently welcoming participants, with the original post dating back to January 1st 2017 and most recent update from November 2nd 2022. The study requires 264 patients from a single location for enrollment."
Share this study with friends
Copy Link
Messenger